Effectiveness of dietary interventions on cardio-metabolic risk factors in patients with nonalcoholic fatty liver disease: a systematic review and meta-analysis of randomized controlled trials

被引:1
|
作者
Ghadimi, Maryam [1 ,2 ]
Mohammadi, Reihaneh [2 ]
Daneshzad, Elnaz [3 ]
Moazzami, Bobak [2 ]
Mohammadpour, Zinat [2 ,4 ]
机构
[1] Univ Tehran Med Sci, Fac Pharm, Dept Clin Pharm, Tehran, Iran
[2] Univ Tehran Med Sci, Liver Transplantat Res Ctr, Imam Khomeini Hosp Complex, Tehran, Iran
[3] Univ Tehran Med Sci, Sch Nutr Sci & Dietet, Dept Community Nutr, Tehran, Iran
[4] Univ Adelaide, Fac Hlth & Med Sci, Adelaide Med Sch, Adelaide, SA, Australia
来源
ANNALS OF GASTROENTEROLOGY | 2021年 / 34卷 / 03期
关键词
Nonalcoholic fatty liver disease; dietary interventions; cardio-metabolic risk factors; insulin resistance; lipid profile; MEDITERRANEAN DIET; AMERICAN ASSOCIATION; HEPATIC STEATOSIS; NATURAL-HISTORY; RESTRICTED DIET; STEATOHEPATITIS; EPIDEMIOLOGY; PATHOGENESIS; MANAGEMENT; DIAGNOSIS;
D O I
10.20524/aog.2021.0601
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background Dietary modification is considered as one of the main strategies in the management of nonalcoholic fatty liver disease (NAFLD). The objective of this study was to systematically investigate the effect of dietary interventions on the cardio-metabolic risk factors, including lipid profile and insulin resistance in this population. Methods We searched electronic databases of PubMed and Scopus until January 2020 and included randomized controlled trials that compared the effect of dietary modifications vs. control on lipid profile and insulin resistance in patients with NAFLD. The random-effect analysis was performed to calculate pooled weighted mean differences (WMD). Results Our finding showed that serum triglycerides (TG) (n=5, WMD -38.50 mg/dL, 95% confidence interval [CI] -61.68 to -15.31; P=0.001) and total cholesterol (TC) (n=4, WMD -18.70 mg/dL, 95%CI -34.85 to -2.53; P=0.023) decrease following diet intervention along with marginally significant weight reduction (n=5, WMD -3.61 mg/dL, 95%CI -7.25 to 0.04; P=0.053). There was no change in the homeostatic model assessment for insulin resistance, high- and low-density lipoprotein (LDL) levels (P>0.05). Subgroup analysis revealed that Mediterranean diet reduced TG (n=2, WMD -57.52 mg/dL, 95%CI -75.73 to -39.31; P<0.001) and weight (n=2, WMD -7.59 Kg, 95%CI -13.53 to -1.66; P=0.012), and also increased LDL level (n=2, WMD 29.73 mg/dL, 95%CI 13.82-45.65; P<0.001). However, standard hypocaloric diet improved TC (n=2, WMD -23.20 mg/dL, 95%CI -36.96 to -9.44; P=0.001) and LDL (n=2, WMD -16.82 mg/dL, 95%CI -29.44 to -4.19; P=0.009). Conclusion Dietary modifications may improve serum TG, TC, and obesity in NAFLD.
引用
收藏
页码:415 / 423
页数:9
相关论文
共 50 条
  • [31] Effectiveness of dietary interventions among adults of retirement age: a systematic review and meta-analysis of randomized controlled trials
    Jose Lara
    Nicola Hobbs
    Paula J Moynihan
    Thomas D Meyer
    Ashley J Adamson
    Linda Errington
    Lynn Rochester
    Falko F Sniehotta
    Martin White
    John C Mathers
    BMC Medicine, 12
  • [32] A Meta-Analysis of Randomized Trials for the Treatment of Nonalcoholic Fatty Liver Disease
    Musso, Giovanni
    Gambino, Roberto
    Cassader, Maurizio
    Pagano, Gianfranco
    HEPATOLOGY, 2010, 52 (01) : 79 - 104
  • [33] Short sleep duration and the risk of nonalcoholic fatty liver disease/metabolic associated fatty liver disease: a systematic review and meta-analysis
    Jie Yang
    Kuo Zhang
    Ziwei Xi
    Yue Ma
    Chunli Shao
    Wenyao Wang
    Yi-Da Tang
    Sleep and Breathing, 2023, 27 : 1985 - 1996
  • [34] Short sleep duration and the risk of nonalcoholic fatty liver disease/metabolic associated fatty liver disease: a systematic review and meta-analysis
    Yang, Jie
    Zhang, Kuo
    Xi, Ziwei
    Ma, Yue
    Shao, Chunli
    Wang, Wenyao
    Tang, Yi-Da
    SLEEP AND BREATHING, 2023, 27 (05) : 1985 - 1996
  • [35] The Effectiveness of Team Reflexivity Interventions: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
    Lines, Robin L. J.
    Pietsch, Simon
    Crane, Monique
    Ntoumanis, Nikos
    Temby, Philip
    Graham, Sally
    Gucciardi, Daniel F.
    SPORT EXERCISE AND PERFORMANCE PSYCHOLOGY, 2021, 10 (03) : 438 - 473
  • [36] Pharmacist Interventions to Improve Cardiovascular Disease Risk Factors in Diabetes A systematic review and meta-analysis of randomized controlled trials
    Santschi, Valerie
    Colosimo, April L.
    Chiolero, Arnaud
    Burnand, Bernard
    Paradis, Gilles
    DIABETES CARE, 2012, 35 (12) : 2706 - 2717
  • [37] The effects of liraglutide on liver enzymes and metabolic factors in patients with nonalcoholic steatohepatitis: a meta-analysis of randomized controlled trials
    Malik, Adnan
    Amjad, Waseem
    Inayat, Faisal
    Nadeem, Mahum
    Weissman, Simcha
    Malik, Muhammad Imran
    Jajja, Ans Ahmad
    Khan, Ahmad
    Tabibian, James H.
    GASTROENTEROLOGY REVIEW-PRZEGLAD GASTROENTEROLOGICZNY, 2023, 18 (01): : 100 - 109
  • [38] EFFECT OF VERY LOW CARBOHYDRATE KETOGENIC DIET ON NONALCOHOLIC FATTY LIVER DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
    Udompap, Prowpanga
    Sripongpun, Pimsiri
    Kaewdech, Apichat
    Gerberi, Danielle
    Churuangsuk, Chaitong
    Allen, Alina M.
    HEPATOLOGY, 2022, 76 : S659 - S659
  • [39] INSULIN SENSITIZERS FOR THE TREATMENT OF NONALCOHOLIC FATTY LIVER DISEASE: A META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
    Rakoski, Mina
    Conjeevaram, Hari S.
    Singal, Amit G.
    HEPATOLOGY, 2010, 52 (04) : 634A - 634A
  • [40] Risk factors of hepatocellular carcinoma associated with nonalcoholic fatty liver disease: Systematic review and meta-analysis
    Yin, Huimin
    Yan, Zhanjie
    Zhao, Fangcheng
    TECHNOLOGY AND HEALTH CARE, 2024, 32 (06) : 3943 - 3954